Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel.
Hudis C, Riccio L, Seidman A, Baselga J, Currie V, Fennelly D, Gilewski T, Lebwohl D, Moynahan M, Raptis G, Surbone A, Sklarin N, Yao TJ, Keefe D, Norton L.
Hudis C, et al.
Cancer Invest. 1998;16(2):67-71. doi: 10.3109/07357909809039759.
Cancer Invest. 1998.
PMID: 9512671
Clinical Trial.
No abstract available.